Logo for Edgewise Therapeutics Inc

Edgewise Therapeutics Investor Relations Material

Latest events

Logo for Edgewise Therapeutics Inc

Study Result

Edgewise Therapeutics
Logo for Edgewise Therapeutics

Q1 2024

9 May, 2024
Logo for Edgewise Therapeutics

Q4 2023

22 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Edgewise Therapeutics Inc

Access all reports
Edgewise Therapeutics Inc. (EWTX) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for severe, rare muscle disorders, addressing significant unmet medical needs. Utilizing its proprietary drug discovery platform, Edgewise focuses on targeting the muscle as an organ, combining expertise in muscle biology and small molecule engineering. This approach allows the identification of precision medicines regulating key proteins in muscle tissue. Edgewise Therapeutics is headquartered in Boulder, Colorado, and its shares are listed on the Nasdaq.